OXBOF (Oxford BioDynamics) Other Stockholders Equity: $4.16 Mil (As of Sep. 2025)


What is Oxford BioDynamics Other Stockholders Equity?

Oxford BioDynamics OXBOF Other Stockholders Equity is $4.16 Mil as of Sep. 2025. The stock has 4 warning signs investors should review.

Oxford BioDynamics's Other Stockholders Equity for the quarter that ended in Sep. 2025 was $4.16 Mil.

Oxford BioDynamics's quarterly Other Stockholders Equity declined from Sep. 2024 ($4.25 Mil) to Mar. 2025 ($3.68 Mil) but then increased from Mar. 2025 ($3.68 Mil) to Sep. 2025 ($4.16 Mil).

Oxford BioDynamics's annual Other Stockholders Equity increased from Sep. 2023 ($3.36 Mil) to Sep. 2024 ($4.25 Mil) but then declined from Sep. 2024 ($4.25 Mil) to Sep. 2025 ($4.16 Mil).

Oxford BioDynamics Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Oxford BioDynamics's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oxford BioDynamics Other Stockholders Equity Chart

Oxford BioDynamics Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.37 3.71 3.36 4.25 4.16

Oxford BioDynamics Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.36 3.72 4.25 3.68 4.16

Oxford BioDynamics Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $4.16 Mil mean?
Oxford BioDynamics (OXBOF) has a Other Stockholders Equity of $4.16 Mil as of Sep. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Oxford BioDynamics and its competitors.
Is Oxford BioDynamics' Other Stockholders Equity too high?
Oxford BioDynamics' current Other Stockholders Equity is $4.16 Mil.
How does Oxford BioDynamics' Other Stockholders Equity compare to TMO and DHR?
Oxford BioDynamics' Other Stockholders Equity of $4.16 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Diagnostics & Research company?
A good Other Stockholders Equity depends on the Medical Diagnostics & Research industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Oxford BioDynamics and its competitors. Oxford BioDynamics's current Other Stockholders Equity is $4.16 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oxford BioDynamics stock overvalued right now?
Based on GuruFocus' analysis, Oxford BioDynamics (OXBOF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.06, compared to a current price of $0.00 — trading 96.7% below its estimated fair value. The current Other Stockholders Equity is $4.16 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Oxford BioDynamics (OXBOF), the current Other Stockholders Equity is $4.16 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Oxford BioDynamics Business Description

Other Exchanges OBD:UKLMQ:Germany
Address John Smith Drive, 3140 Rowan Place, Oxford Business Park South, Oxford, GBR, OX4 2WB
Oxford BioDynamics PLC is a biotechnology company focused on advancing personalized healthcare through the development and commercialization of precision medicine tests for serious and impactful diseases. The company is engaged in the commercialisation of proprietary molecular diagnostics products and biomarker research and development. It has two commercially available products: the EpiSwitch PSE (EpiSwitch Prostate Cancer Detection Test) and EpiSwitch CiRT (Checkpoint Inhibitor Response Test) blood tests. The company generates revenue from the sales of proprietary products and biomarker research and development. Geographically, it generates the maximum revenue from the USA.